Celleration initiates enrollment in MIST Therapy research for VLU Celleration, Inc., a privately-held medical device company focused on developing and commercializing therapeutic ultrasound healing technologies, announced the first individual enrollment in IN-Stability VLU . Related StoriesCombination of ultrasound and mammography detects additional cancers in Japanese womenMesenchymal stem cell exosomes present hope in healing persistent woundsClinical trial initiated to determine feasibility, protection of focused ultrasound to treat depressionIN-BALANCE VLU is a prospective, randomized, controlled, multi-center study of MIST Therapy in persistent lower extremity venous ulcers . The analysis will become performed at up to 20 study centers with an estimated 124 subjects signed up for the study overall.Bioject Medical Systems collaborates with MPI Analysis to explore medication and device opportunities Bioject Medical Systems Inc. , a respected developer of needle-free of charge injection therapy systems, announced that it has generated a strategic alliance with MPI Research today, a respected pre-clinical research business with encounter in the advancement of injectable therapeutics. It is a enjoyment to collaborate with a ongoing company which has such highly-developed technological experience and strategic vision. This alliance also escalates the probability that Bioject and MPI Study might be able to protected federal government sponsored grants or financing fond of improvements in drug+gadget or vaccine+gadget based treatments, that could also result in potential new drug+gadget combinations.